This page lists the SEC filings reported by Greenlight Capital.
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | GREENLIGHT CAPITAL INC | CONSOL Energy Inc. | 676,724 | 2.2% | EDGAR |
| SC 13G/A | 2024-02-14 | GREENLIGHT CAPITAL INC | Coya Therapeutics, Inc. | 439,762 | 3.1% | EDGAR |
| SC 13G/A | 2024-02-14 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 63,579 | 1.7% | EDGAR |
| SC 13G/A | 2024-02-14 | GREENLIGHT CAPITAL INC | Talis Biomedical Corp | 70,116 | 3.9% | EDGAR |
| SC 13D/A | 2023-12-12 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 834,545 | 1.8% | EDGAR |
| SC 13G | 2023-12-12 | GREENLIGHT CAPITAL INC | Coya Therapeutics, Inc. | 442,037 | 3.1% | EDGAR |
| SC 13D/A | 2023-12-05 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 834,545 | 1.8% | EDGAR |
| SC 13D/A | 2023-09-11 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 834,545 | 1.8% | EDGAR |
| SC 13D/A | 2023-09-08 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 834,545 | 1.8% | EDGAR |
| SC 13D/A | 2023-08-04 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 834,545 | 1.8% | EDGAR |
| SC 13D/A | 2023-06-30 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 834,545 | 1.8% | EDGAR |
| SC 13G/A | 2023-02-14 | GREENLIGHT CAPITAL INC | Talis Biomedical Corp | 1,051,739 | 3.9% | EDGAR |
| SC 13G/A | 2023-02-14 | GREENLIGHT CAPITAL INC | CONSOL Energy Inc. | 806,138 | 2.3% | EDGAR |
| SC 13D/A | 2022-08-05 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 8,348,478 | 18.1% | EDGAR |
| SC 13D/A | 2022-05-06 | GREENLIGHT CAPITAL INC | Green Brick Partners, Inc. | 8,480,328 | 17.5% | EDGAR |
| SC 13G/A | 2022-02-14 | GREENLIGHT CAPITAL INC | CONSOL Energy Inc. | 983,318 | 2.9% | EDGAR |
| SC 13G/A | 2022-02-14 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 1,271,596 | 3.9% | EDGAR |
| SC 13G/A | 2022-02-14 | GREENLIGHT CAPITAL INC | ATLAS AIR WORLDWIDE HOLDINGS INC | 336,148 | 1.2% | EDGAR |
| SC 13G | 2022-02-14 | GREENLIGHT CAPITAL INC | Talis Biomedical Corp | 737,621 | 2.8% | EDGAR |
| SC 13G/A | 2021-02-16 | GREENLIGHT CAPITAL INC | NeuBase Therapeutics, Inc. | 945,196 | 4.1% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.